Quidel | QDEL - Selling And Administration Expenses


Quidel reported $199.3M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Agilent USD 465M 11M Mar/2026
Avanos Medical USD 77.7M 1.1M Mar/2026
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Bruker USD 242.1M 5.1M Mar/2026
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Danaher USD 1.86B 166M Mar/2026
Haemonetics USD 109.15M 7.54M Dec/2025
Illumina USD 272M 11M Mar/2026
IQVIA Holdings USD 502M 34M Mar/2026
Merit Medical Systems USD 110.47M 4.36M Mar/2026
Mettler Toledo International USD 258.33M 1.5M Mar/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
Neogen USD 98.5M 9M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Quidel USD 199.3M 4.9M Mar/2026
Revvity USD 253.88M 2.15M Mar/2026
STAAR Surgical USD 38.64M 299K Mar/2026
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Waters USD 394M 153.99M Mar/2026